Olink Holding AB (OLK)
22.84
-0.23
(-1.00%)
USD |
NASDAQ |
Apr 26, 16:00
22.80
-0.04
(-0.15%)
After-Hours: 20:00
Olink Price to Book Value: 5.650 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 5.650 |
| April 25, 2024 | 5.706 |
| April 24, 2024 | 5.548 |
| April 23, 2024 | 5.491 |
| April 22, 2024 | 5.449 |
| April 19, 2024 | 5.410 |
| April 18, 2024 | 5.508 |
| April 17, 2024 | 5.513 |
| April 16, 2024 | 5.605 |
| April 15, 2024 | 5.625 |
| April 12, 2024 | 5.644 |
| April 11, 2024 | 5.696 |
| April 10, 2024 | 5.736 |
| April 09, 2024 | 5.726 |
| April 08, 2024 | 5.748 |
| April 05, 2024 | 5.756 |
| April 04, 2024 | 5.788 |
| April 03, 2024 | 5.838 |
| April 02, 2024 | 5.810 |
| April 01, 2024 | 5.813 |
| March 28, 2024 | 5.815 |
| March 27, 2024 | 5.838 |
| March 26, 2024 | 5.951 |
| March 25, 2024 | 6.043 |
| March 22, 2024 | 6.013 |
| Date | Value |
|---|---|
| March 21, 2024 | 5.951 |
| March 20, 2024 | 5.983 |
| March 19, 2024 | 5.974 |
| March 18, 2024 | 5.964 |
| March 15, 2024 | 5.919 |
| March 14, 2024 | 5.924 |
| March 13, 2024 | 5.924 |
| March 12, 2024 | 5.887 |
| March 11, 2024 | 5.880 |
| March 08, 2024 | 5.850 |
| March 07, 2024 | 5.800 |
| March 06, 2024 | 5.761 |
| March 05, 2024 | 5.689 |
| March 04, 2024 | 5.687 |
| March 01, 2024 | 5.692 |
| February 29, 2024 | 5.533 |
| February 28, 2024 | 5.578 |
| February 27, 2024 | 5.573 |
| February 26, 2024 | 5.417 |
| February 23, 2024 | 5.395 |
| February 22, 2024 | 5.439 |
| February 21, 2024 | 5.444 |
| February 20, 2024 | 5.625 |
| February 16, 2024 | 6.107 |
| February 15, 2024 | 6.112 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.345
Minimum
Jun 14 2022
14.30
Maximum
Mar 25 2021
5.677
Average
5.640
Median
Price to Book Value Benchmarks
| Thermo Fisher Scientific Inc | 4.812 |
| Abliva AB | 1.504 |
| Karolinska Development AB | 0.5612 |
| Calliditas Therapeutics AB | 15.74 |
| Oncopeptides AB | 2.915 |
Price to Book Value Related Metrics
| PS Ratio | 16.70 |
| PEG Ratio | -0.6091 |
| Price | 22.84 |
| Earnings Yield | -1.09% |
| Market Cap | 2.840B |
| PEGY Ratio | -0.6091 |